A detailed history of Cookson Peirce & CO Inc transactions in Argenx Se stock. As of the latest transaction made, Cookson Peirce & CO Inc holds 23,566 shares of ARGX stock, worth $13.3 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
23,566
Holding current value
$13.3 Million
% of portfolio
0.61%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$434.22 - $551.9 $10.2 Million - $13 Million
23,566 New
23,566 $12.8 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $31.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Cookson Peirce & CO Inc Portfolio

Follow Cookson Peirce & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cookson Peirce & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cookson Peirce & CO Inc with notifications on news.